SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-22-000009
Filing Date
2022-02-22
Accepted
2022-02-22 16:11:17
Documents
19
Period of Report
2022-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20220215.htm   iXBRL 8-K 54912
2 EX-10 exhibit10formof2022-2024.htm EX-10 17835
6 GRAPHIC exhibit10formof2022-2024001.jpg GRAPHIC 232767
7 GRAPHIC exhibit10formof2022-2024002.jpg GRAPHIC 243349
8 GRAPHIC exhibit10formof2022-2024003.jpg GRAPHIC 188114
9 GRAPHIC exhibit10formof2022-2024004.jpg GRAPHIC 190079
10 GRAPHIC exhibit10formof2022-2024005.jpg GRAPHIC 240453
11 GRAPHIC exhibit10formof2022-2024006.jpg GRAPHIC 155698
  Complete submission text file 0001367644-22-000009.txt   1946841

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20220215.xsd EX-101.SCH 1965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20220215_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20220215_pre.xml EX-101.PRE 13100
13 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20220215_htm.xml XML 11437
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 22658156
SIC: 2834 Pharmaceutical Preparations